Patents

Treatment of Mucocutaneous Disorders through Reversing Chronic Inflammation and Barrier Disruption.
Filed with US Patent Office- 2002 -2006; Continuation in Progress.

Method and Compositions for Disrupting Epithelial Barrier Function.
U.S. Patent 6,190,894. Granted 02/20/2001.

Pyridine-thiols reverse mucocutaneous aging.
U.S. Patent 6,071,593. Granted 06/06/2000.

Topical active agents to enhance the penetration of excipients.
U.S. Patent 5,760,096.  Granted 06/02/1998.

Lipids for epidermal moisturization and repair of barrier function.
U.S. Patent 5,643,899. Granted 01/01/1997.

Use of dicarboxylic acids / analogs as penetration enhancers and toxicity blunting agents.
U.S. Patent 5,326,790. Granted 07/05/1994.

Treatment of a) skin disorders, b) skin tumors induced by viruses, and c) hyperpigmentation disorders all with monocarboxylic lipids. 
U.S. Patent 5,231,087. Granted 07/27/1993.

Treatment of viral tumors and hemorrhoids with sesquiterpenes. 
U.S. Patent 5,219,880. Granted 06/15/1993.

Treatment of papulosquamous and eczematous diseases with combinations of carboxylic lipids and sesquiterpenes.
U.S. Patent 5,057,501. Granted 10/15/1991.

Treatment of pruritus with monocarboxylic lipids. 
U.S. Patent 5,057,500.  Granted 10/15/1991.

Treatment of psoriasis with sesquiterpenes. 
U.S. Patent 4,978,676.  Granted 12/18/1990.

Treatment of inflammatory and / or hyperproliferative skin diseases in which pathogenic microbes play a significant role with amines of carboxylic lipids.
U.S. Patent 4,868,219. Granted 08/19/1989.

Treatment of hyperhidrosis, ichthyosis and wrinkling with mono-and dicarboxylic lipids.
U.S. Patent 4,885,282.  Granted 12/05/1989.

Treatment of non-acne inflammatory dermatoses, infectious cutaneous disease, and hair loss with dicarboxylic lipids. 
U.S. Patent 4,713,394.  Granted 12/15/1987.